Medicamen Biotech Ltd vs Ortin Global Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Medicamen Biotech Ltd is ₹ 229.45 as of 12 Jun 15:30 . The P/E Ratio of Medicamen Biotech Ltd changed from 53.8 on March 2021 to 86.2 on March 2025 . This represents a CAGR of 9.89% over 5 yearsThe P/E Ratio of Ortin Global Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Medicamen Biotech Ltd changed from ₹ 652.37 crore on March 2021 to ₹ 612.46 crore on March 2025 . This represents a CAGR of -1.25% over 5 yearsThe Market Cap of Ortin Global Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Medicamen Biotech Ltd for the Mar '26 is ₹ 62.38 crore as compare to the Dec '25 revenue of ₹ 47.44 crore. This represent the growth of 31.49% The revenue of Ortin Global Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Medicamen Biotech Ltd for the Mar '26 is ₹ 7.18 crore as compare to the Dec '25 ebitda of ₹ 4.91 crore. This represent the growth of 46.23% The ebitda of Ortin Global Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Medicamen Biotech Ltd changed from ₹ 0.8 crore to ₹ 4.45 crore over 8 quarters. This represents a CAGR of 135.85% The net profit of Ortin Global Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Medicamen Biotech Ltd changed from 9.78 % on March 2021 to 13.45 % on March 2025 . This represents a CAGR of 6.58% over 5 yearsThe Dividend Payout of Ortin Global Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Medicamen Biotech Ltd

A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets.
The Company has presence over 35+ countries.
Its offerings include Finished Dosage Forms (FDF's) to African countries. In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market.
MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan).
The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others.

About Ortin Global Ltd

Ortin Global Limited was initially incorporated as Ortin Laboratories Limited in October 1986 to offer quality Drugs and Medicines to the suffering mankind.
Name of the Company was changed from Ortin Laboratories Limited to Ortin Global Limited with due approval from the ROC, Ministry of Corporate Affairs on June 14, 2024. Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India.
It is engaged in manufacturing and trading of pharmaceuticals, Drugs and Intermediates, to manufacture, sell or export all types of medicines including ayurvedic, homeopathic, unani, biochemical, nature cure, etc and also to engage in real estate. Apart from this, Company also manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India.

FAQs for the comparison of Medicamen Biotech Ltd and Ortin Global Ltd

Which company has a larger market capitalization, Medicamen Biotech Ltd or Ortin Global Ltd?

Market cap of Medicamen Biotech Ltd is 311 Cr while Market cap of Ortin Global Ltd is 14 Cr

What are the key factors driving the stock performance of Medicamen Biotech Ltd and Ortin Global Ltd?

The stock performance of Medicamen Biotech Ltd and Ortin Global Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Medicamen Biotech Ltd and Ortin Global Ltd?

As of June 14, 2026, the Medicamen Biotech Ltd stock price is INR ₹229.45. On the other hand, Ortin Global Ltd stock price is INR ₹17.35.

How do dividend payouts of Medicamen Biotech Ltd and Ortin Global Ltd compare?

To compare the dividend payouts of Medicamen Biotech Ltd and Ortin Global Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.